Neonatal Marfan syndrome is a rare, severe form of Marfan syndrome that is usually recognized before birth or in the first weeks of life. Babies with neonatal Marfan syndrome often have long fingers, very flexible joints, feeding and breathing problems, and serious heart valve disease that can lead to heart failure. The condition is lifelong, and the early signs of neonatal Marfan syndrome can worsen quickly during infancy. Treatment focuses on close heart care, medicines, support for breathing and feeding, and sometimes surgery. It may help to know that doctors have studied this condition for decades, but neonatal Marfan syndrome can be life-threatening in early childhood, especially when the heart is severely affected.
How many people live with Neonatal marfan syndrome?
There is no reliable current count of how many people are living with neonatal Marfan syndrome worldwide or in the United States; major rare-disease references describe it as extremely rare and do not give firm global or U.S. totals (Orphanet, 2024; Genetic and Rare Diseases Information Center, 2024). For context, Marfan syndrome overall is often estimated to affect about 1 in 5,000 people, or roughly 1.6 million people worldwide and about 67,000 people in the United States when that rate is applied to current population totals (National Marfan Foundation, 2024), but no widely accepted share of cases is available for the neonatal form, so a trustworthy neonatal Marfan estimate cannot be given.
Overview
Neonatal marfan syndromeSymptoms
Neonatal Marfan syndrome causes severe signs soon after birth. Babies often have long fingers, loose joints, poor feeding, breathing trouble, and heart valve problems, and many living with neonatal Marfan syndrome need urgent specialist care.
Outlook and prognosis
Neonatal marfan syndrome is usually the most severe form of Marfan syndrome, with serious heart and breathing problems starting in infancy. Many babies need intensive specialist care, and outlook depends largely on how severe the early heart valve disease is.
Causes and risk factors
Neonatal Marfan syndrome is caused by a change in the FBN1 gene, usually a new change but sometimes inherited from a parent. Family history raises risk, while lifestyle or environmental factors do not cause it, though they may affect complications.
Genetic influences
Genetics are central to Neonatal marfan syndrome. It is usually caused by a change in the FBN1 gene, and different genetic variants can affect how severe Neonatal marfan syndrome is and which early symptoms of Neonatal marfan syndrome appear.
Diagnosis
Neonatal Marfan syndrome is diagnosed from clinical features seen soon after birth, often including heart findings and body features. Doctors usually confirm the diagnosis of Neonatal Marfan syndrome with genetic tests and imaging such as echocardiography.
Treatment and drugs
Treatment for Neonatal Marfan syndrome focuses on the heart, lungs, and feeding, often with medicines to ease heart strain and support breathing. Many babies also need close specialist care, nutrition support, and sometimes surgery for serious heart valve problems.
Symptoms
From the first days or weeks of life, babies with neonatal Marfan syndrome often have feeding, breathing, and growth challenges alongside noticeable body features. Some of the early features of neonatal Marfan syndrome include unusually long fingers and toes, a long body, joint changes, and a chest that looks sunken or pushed outward. Heart problems are also common and can make babies tire easily, breathe fast, or struggle to gain weight. The pattern can vary, but this form of Marfan syndrome is usually more severe in infancy than the more familiar type seen later in childhood or adulthood.
Babies often have unusually long arms, legs, fingers, and toes, with very slender hands and feet. The body may also look long and slim, and the skin can seem loose or less firm than expected.
Joints may be very loose, but some joints can also stay bent or not straighten fully. This can affect how a baby holds their arms, legs, hands, or feet during everyday movement and care.
The chest may look sunken inward or pushed outward, and the spine may begin to curve. In some babies, these shape changes add to the work of breathing.
Many babies have a long, narrow face, deep-set eyes, and ears that look soft, folded, or crumpled. Doctors may notice this pattern during an exam, even before all features are fully obvious.
How people usually first notice Neonatal marfan syndrome?
Neonatal Marfan syndrome is usually first noticed at birth or in the first weeks of life, when doctors or parents see unusually long fingers and toes, long limbs, loose or wrinkled skin, and joints that seem stiff in some places but overly flexible in others. The first signs of neonatal Marfan syndrome often also include feeding trouble, poor weight gain, a weak cry, breathing problems, or a heart murmur, because this rare form tends to affect the heart and lungs very early. For many families, how neonatal Marfan syndrome is first noticed is that a newborn simply seems medically fragile from the start, which leads doctors to look more closely at the baby’s physical features and heart.
Types of Neonatal marfan syndrome
No distinct types of Neonatal Marfan syndrome are widely recognized.
Can I slow down the onset of symptoms?
No, there is no good evidence that lifestyle changes or routine preventive treatment can meaningfully delay the start of symptoms in neonatal Marfan syndrome, because this severe form usually begins before birth or in the first weeks of life. Unlike conditions that develop later, factors like diet, exercise, sleep, or mental activity have not been shown to push back the onset, and current research is mainly focused on finding better treatments rather than preventing the condition from starting. Early care from heart and genetics specialists, with regular heart scans and medicines or surgery when needed, cannot prevent neonatal Marfan syndrome but can help treat serious problems early, and close follow-up can still make an important difference.
What genetics can tell you about symptoms
In neonatal Marfan syndrome, genetics can give some clues about symptoms because changes in the FBN1 gene are linked to how severe the condition may be, especially when they affect certain parts of the gene. Many living with this condition have serious heart valve problems, loose joints, long fingers and toes, feeding trouble, and breathing problems very early in life, often in the newborn period or first months. Still, genetics cannot predict every detail, and even with a known gene change, the exact mix of symptoms and how quickly they progress can vary from child to child.
Causes and risk factors
Babies with neonatal Marfan syndrome often have early heart, breathing, and feeding problems because of a harmful change in the FBN1 gene. This change can be inherited from a parent, but it more often happens for the first time in the child. Family history raises the chance in future children, and the exact gene change can affect how severe it is. Lifestyle, diet, and common pregnancy exposures are not known to cause neonatal Marfan syndrome. Genetic testing can sometimes clarify your personal risk.
What are the most common causes or risk factors?
Neonatal Marfan syndrome is almost always caused by a change in a gene called FBN1, which affects connective tissue, the body’s support material for the heart, blood vessels, eyes, bones, and joints. In many babies, this gene change happens for the first time by chance, but it can also be inherited from a parent with Marfan syndrome, so having an affected parent is the main known risk factor. There are no known lifestyle, diet, or pregnancy-related factors that cause this condition.
Environmental and biological risk factors
When families ask about risk factors for neonatal Marfan syndrome, the short answer is that most known risks are body-based and start before birth. Some risks are carried inside the body, others come from the world around us. For neonatal Marfan syndrome, clear environmental causes have not been identified, and routine pregnancy or newborn care is not known to trigger it.
If one parent is living with Marfan syndrome, the chance of a baby having a related condition is higher than in the general population. Even so, the newborn form is uncommon, and family history alone cannot predict how severe it will be.
Many babies with neonatal Marfan syndrome are born into families with no previous history of it. In these cases, the main risk comes from a biological change that arose very early before birth, not from anything parents did or did not do.
No well-established environmental exposures during pregnancy have been shown to cause neonatal Marfan syndrome. That can be reassuring for families who worry about everyday activities, foods, or common illnesses during pregnancy.
Problems during labor, delivery, or care right after birth are not known to increase the chance that neonatal Marfan syndrome will occur. The condition begins before birth rather than being caused by the birth itself.
Genetic risk factors
In neonatal Marfan syndrome, the main risk comes from a change in a gene that affects the body’s stretchy support tissues, so problems can begin very early in life. Some risk factors are inherited through our genes. Most genetic causes of neonatal Marfan syndrome involve the FBN1 gene, and many happen for the first time in the child rather than being passed down from a parent.
FBN1 gene: Nearly all cases of neonatal Marfan syndrome are caused by a change in FBN1, the gene that makes fibrillin-1, a protein that helps support connective tissue. When this gene is altered, tissues in the heart, blood vessels, lungs, joints, and eyes can be unusually weak or stretchy.
New mutation: In many babies, the FBN1 change is new, meaning it started in the child and was not known in either parent before pregnancy. This is why a family history is often absent.
Specific region: The severe newborn form is especially linked to changes in a middle part of FBN1, often called exons 24 through 32. Variants in this region are more likely to cause symptoms very early and to strongly affect the heart and breathing.
Dominant inheritance: If a parent carries an FBN1 change that can cause neonatal Marfan syndrome, each pregnancy has a 1 in 2, or 50%, chance of passing it on. The exact severity can still vary from one family member to another.
Parental mosaicism: Rarely, a parent has the gene change in only some egg, sperm, or body cells, which is called mosaicism. This can slightly raise the chance of neonatal Marfan syndrome happening again even when both parents seem unaffected.
Lifestyle risk factors
Neonatal Marfan syndrome is not caused by lifestyle habits, but everyday care choices can still affect how symptoms unfold and how complications are managed. In this condition, how lifestyle affects Neonatal Marfan syndrome is mainly seen through feeding, physical handling, activity balance, and routines that influence breathing and heart strain. Because babies with this disorder often have severe heart, lung, and growth challenges, lifestyle risk factors for Neonatal Marfan syndrome are mostly caregiver-controlled factors that can either ease or worsen daily stress on the body.
Poor feeding routines or delayed nutrition support can worsen failure to thrive in babies with Neonatal Marfan syndrome. Smaller, more frequent feeds and close attention to swallowing fatigue may help reduce breathing effort and improve weight gain.
Inadequate calories can be especially harmful because these infants often use extra energy for breathing and circulation. Nutrition plans tailored to growth needs may support strength, healing, and tolerance of medical treatment.
Overstimulation or activity that causes marked fatigue can increase breathing difficulty and cardiovascular stress. Gentle, paced interaction with rest breaks is usually better tolerated than prolonged handling or exhausting play.
Rough handling or positions that overextend lax joints can add discomfort and mechanical stress to fragile connective tissues. Supportive positioning and careful lifting may help limit pain and reduce strain on the spine, hips, and limbs.
Risk prevention
Neonatal Marfan syndrome is a rare genetic condition present from birth, so there is no proven way to prevent the condition itself from happening. In practice, prevention means lowering the risk of complications by catching heart, breathing, feeding, and vision problems early and treating them promptly. Prevention works best when combined with regular check-ups, because babies with neonatal Marfan syndrome can become unwell quickly if problems are missed.
Regular follow-up with a cardiologist, genetic specialist, and other experienced clinicians can help spot changes before they become emergencies. This is especially important because some early symptoms of neonatal Marfan syndrome, such as fast breathing, poor feeding, or trouble gaining weight, can worsen quickly.
Frequent heart scans and blood pressure checks can help detect valve problems or heart enlargement early. Timely treatment may reduce strain on the heart and lower the risk of heart failure.
Watching closely for noisy breathing, rapid breathing, or repeated chest infections can help prevent serious lung and airway complications. Some babies may need respiratory support, reflux treatment, or airway assessment to keep breathing as safe as possible.
Early help from feeding specialists can lower the risk of poor growth, choking, and dehydration. For many living with neonatal Marfan syndrome, this can mean adjusted feeding techniques, higher-calorie nutrition, or tube feeding when needed.
Can you prevent Neonatal marfan syndrome?
No, neonatal Marfan syndrome usually cannot be prevented, because it is caused by a gene change that happens before birth and is not something parents can control with diet, activity, or other lifestyle steps. If Marfan syndrome runs in the family, meeting with a genetics specialist before or during pregnancy can help explain the chances and discuss testing options, but it cannot guarantee prevention.
Transmission
Neonatal Marfan syndrome is not infectious, so it cannot be caught from another person through touch, coughing, kissing, food, or blood. For families, the key question is how neonatal Marfan syndrome is inherited: it happens because of a change in a gene that affects connective tissue, not because of exposure to an infection.
Many babies with neonatal Marfan syndrome have a new gene change that started around conception, even when no one else in the family has it. In some families, the altered gene is passed from a parent in an autosomal dominant pattern, which means one changed copy is enough to cause the condition and each pregnancy has a 1 in 2, or 50%, chance of inheriting it.
When to test your genes
Genetic testing is most useful as soon as neonatal Marfan syndrome is suspected, especially in a newborn with long fingers, loose joints, heart valve problems, or breathing difficulties, or when a parent carries an FBN1 variant. Early confirmation helps guide heart monitoring, treatment choices, and family planning.
Diagnosis
Neonatal Marfan syndrome is usually diagnosed very early in life because the pattern of findings can be striking, often involving the heart, joints, face, and breathing. Babies may come to medical attention when feeding is difficult, breathing seems hard work, or a doctor hears a heart murmur during a routine exam. Getting a diagnosis is often a turning point toward answers and support. The diagnosis of Neonatal Marfan syndrome is based on this clinical picture and confirmed with targeted testing.
Doctors look for a recognizable combination of features, such as very long fingers and toes, loose joints, tight or bent fingers, and a long, narrow body shape. They also check for facial features and skin findings that fit Neonatal Marfan syndrome.
An echocardiogram uses sound waves to look closely at the heart valves and the main blood vessel leaving the heart. This is a key part of diagnosis because severe valve leakage and enlargement of the aorta are common in Neonatal Marfan syndrome.
Doctors assess breathing effort, oxygen levels, and signs that the airways or lungs are under strain. Chest imaging may be used if a baby has respiratory symptoms or if the exam suggests related problems.
A detailed eye examination can look for lens problems and other eye changes linked to Marfan-related conditions. Eye findings may support the diagnosis, although they are not always the main clue in newborns.
How is Neonatal marfan syndrome diagnosed?
Neonatal Marfan syndrome is usually diagnosed by a specialist who looks at a baby's physical signs and early health problems, especially the combination of very long arms, legs, fingers, loose joints, and serious heart valve trouble. Doctors often use a heart ultrasound, called an echocardiogram, and may also do an eye exam and review family history, because the pattern of findings matters more than any one sign alone. A DNA test can help confirm the diagnosis by looking for a change in the fibrillin-1 gene, but it is usually used along with the baby's symptoms and exam findings.
Stages of Neonatal marfan syndrome
Neonatal marfan syndrome does not have defined progression stages. That is because it is a severe form of Marfan syndrome that is recognized by a pattern of problems present very early in life, rather than by a step-by-step decline over time. Doctors usually start with a conversation about pregnancy, birth, feeding, breathing, and family history, then combine that with a physical exam, heart imaging such as an echocardiogram, and often an eye exam. Because the early symptoms of neonatal Marfan syndrome can affect the heart, lungs, and growth, babies are usually monitored closely over time to see how these problems are changing and what support is needed.
Outlook and prognosis
The outlook for neonatal Marfan syndrome is generally poor because the condition is usually more severe than classic Marfan syndrome and often causes rapidly progressive heart valve disease and heart failure in infancy. Many affected infants develop serious mitral and tricuspid valve dysfunction, breathing difficulties, feeding problems, and poor growth, which can require intensive medical and surgical care. Mortality is high in early childhood, and historically many children died within the first 1 to 2 years of life, most often from cardiovascular complications. Prognosis varies depending on the severity of cardiac involvement and how well symptoms can be managed with medications, respiratory support, and sometimes surgery. A small number of children survive longer with aggressive multidisciplinary care, but they usually continue to have significant medical needs and require lifelong monitoring by cardiology, genetics, and other specialists.
Long-term effects
Neonatal Marfan syndrome can affect many parts of the body from the start, but the long-term outlook is most strongly shaped by how severely the heart, blood vessels, and lungs are involved. Long-term effects vary widely, although this form is usually more severe than classic Marfan syndrome and often causes serious health problems early in life. For many families, questions about life expectancy in neonatal Marfan syndrome come up quickly because some children become critically ill in infancy, while others live longer with ongoing medical needs.
The most serious long-term effect is often severe strain on the heart caused by leaky heart valves. Over time, this can lead to poor pumping strength, fluid buildup, and repeated episodes of serious illness.
The body’s main artery may become stretched and weak early in life. This raises the risk of dangerous complications as the child grows, although the degree and speed of change can differ.
Many living with neonatal Marfan syndrome have long-term breathing trouble related to weak airways, chest shape differences, or pressure from an enlarged heart. In day-to-day life, this can mean fast breathing, tiring with feeds, or needing extra breathing support.
Feeding difficulties and the extra work of breathing can make it hard to gain weight and grow steadily. Some children remain smaller or more medically fragile because their bodies use so much energy just to keep up.
How is it to live with Neonatal marfan syndrome?
Living with neonatal Marfan syndrome usually means living with a condition that affects many parts of the body from the very start, often with serious heart, breathing, and feeding problems that can require frequent medical visits, medicines, and sometimes hospital care. For many living with this condition, daily life is shaped by careful monitoring, support with growth and comfort, and the uncertainty that comes with symptoms that can change quickly. Family members and other caregivers are often deeply involved in day-to-day care and medical decisions, which can be emotionally and physically demanding, but many also find that clear care plans and strong support from specialists help them feel more prepared and less alone.
Treatment and drugs
Neonatal Marfan syndrome is treated with close, ongoing care aimed at the problems it causes in the heart, lungs, feeding, and growth, often starting soon after birth. Treatment plans often combine several approaches. Many babies with neonatal Marfan syndrome need medicines to reduce stress on the heart and major blood vessels, and some also need drugs to help with heart failure symptoms such as fast breathing, poor feeding, or trouble gaining weight. Because this form of Marfan syndrome can affect the heart valves very early, some infants may need surgery or intensive hospital care, while others also benefit from feeding support, breathing support, and physical or developmental therapies. Not every treatment works the same way for every person, so doctors usually follow babies very closely and adjust care as their needs change.
Can you cure Neonatal marfan syndrome?
No, there is currently no cure for neonatal Marfan syndrome. Treatment focuses on managing the problems it causes, especially serious heart issues, breathing trouble, feeding problems, and poor growth, and this may include medicines, close monitoring, and sometimes surgery. Because this form is often severe and starts very early in life, care usually involves a team of specialists to improve comfort and support the best possible quality of life.
Non-drug treatment
Daily care for Neonatal marfan syndrome often centers on breathing, feeding, movement, and close follow-up from several specialists. Babies and children living with Neonatal marfan syndrome may tire easily, struggle to gain weight, or need help with joints, vision, and development. Managing this condition often means building a supportive plan around home care, therapy, nutrition, and procedures when needed.
Many infants with Neonatal marfan syndrome burn a lot of energy and may have trouble feeding well enough to grow. Feeding therapy, calorie-rich nutrition plans, and sometimes tube feeding can help with weight gain and reduce exhaustion during feeds.
Breathing problems can be a major part of daily life, especially if the chest shape, airways, or heart disease make it harder to get enough air. Non-drug treatments may be recommended early, including oxygen, breathing support devices, or hospital-based respiratory care when needed.
Loose joints, muscle weakness, and long limbs can make holding the head up, sitting, or moving around more difficult. Physical therapy can support strength, positioning, and motor development while helping prevent discomfort from unstable joints.
Occupational therapy focuses on everyday skills such as feeding, grasping toys, posture, and safe positioning. Some strategies can slip naturally into your routine—like supported seating or gentle hand exercises—so daily care feels more manageable.
Your genes may have an impact on how drugs work for you
For babies living with neonatal Marfan syndrome, medicines are often used to ease strain on the heart and blood vessels, but the exact genetic change causing the condition does not usually guide which medicine works best the way it does in some other illnesses. In everyday care, response to treatment is more often shaped by how seriously the heart is affected, the baby’s size and age, and how well the body handles the medicine. Because this condition can vary a lot from one baby to another, doctors usually adjust treatment by watching symptoms and heart test results closely rather than relying on special gene-based drug matching.
Pharmacological treatments
In neonatal Marfan syndrome, medicines are mainly used to ease strain on the heart and blood vessels, rather than to cure the condition itself. Medication can feel like a big step, but these drugs are often part of a broader treatment for neonatal Marfan syndrome that may also include close heart monitoring and sometimes surgery. The exact drug plan depends on what is happening day to day, such as heart failure symptoms, fast breathing, poor feeding, or enlargement of the aorta. Because this form of Marfan syndrome is often severe, treatment is usually guided by a pediatric cardiology team.
Propranolol or atenolol may be used to slow the heartbeat and reduce stress on the aorta. In some babies, this can help limit how forcefully blood hits the weakened vessel wall.
Losartan is sometimes used to help protect the aorta as it enlarges. Many living with neonatal Marfan syndrome need careful dose adjustment because not everyone responds to the same medication in the same way.
Captopril or enalapril may be prescribed when the heart is struggling or leaking valves are causing extra workload. These medicines help blood move forward more easily by lowering resistance in the circulation.
Furosemide and sometimes spironolactone are used to remove extra fluid when heart failure leads to fast breathing, sweating with feeds, or poor weight gain. For many, this can mean a baby is less breathless during feeding and more comfortable between feeds.
Genetic influences
In neonatal Marfan syndrome, the genetic cause is clear: it results from a change in the FBN1 gene, which helps the body make a key connective-tissue protein. This condition is inherited in an autosomal dominant way, meaning a parent with the gene change has a 1 in 2, or 50%, chance of passing it to each child. Many babies with neonatal Marfan syndrome, however, are the first in their family to be affected because the gene change happened for the first time in that child. It’s natural to ask whether family history plays a role. Compared with more typical Marfan syndrome, this early and severe form is often linked to changes in a particular part of FBN1, which helps explain why problems begin so soon after birth. Genetic testing for neonatal Marfan syndrome can usually confirm the diagnosis and helps families understand the chance of it happening again in future pregnancies.
Is Neonatal marfan syndrome genetic?
Genetics are central to Neonatal marfan syndrome. It is usually caused by a change in the FBN1 gene, and different genetic variants can affect how severe Neonatal marfan syndrome is and which early symptoms of Neonatal marfan syndrome appear.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are found commonly throughout the population. Most of these variants do not directly affect health and are simply part of normal human diversity. In many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, especially when several genes and environmental factors both play a role. In some situations, though, one well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
When families ask how genetics affect treatment for neonatal Marfan syndrome, the main answer is that the gene change often tells doctors how severe the condition may be and how closely a baby needs to be watched. In many infants, certain changes in the FBN1 gene are linked with more serious heart valve problems, enlargement of the aorta, and breathing or feeding difficulties, so care is usually planned early and involves several specialists. This can shape treatment choices, including how soon doctors consider medicines that reduce strain on the heart and aorta, such as beta blockers or angiotensin receptor blockers, and whether surgery may be needed sooner.
Not every difference in response is genetic, but for neonatal Marfan syndrome, genetics currently guides the overall treatment plan more than it guides drug selection in a pharmacogenetics sense. In other words, there is no well-established gene test that reliably tells doctors which heart medicine will work best or what exact dose a newborn should receive just because they have neonatal Marfan syndrome. Instead, treatment is tailored by combining the genetic result with echocardiogram findings, breathing status, growth, feeding, and how the baby responds over time.
Interactions with other conditions
For families living with neonatal Marfan syndrome, day-to-day challenges often come less from the name itself and more from how heart, breathing, and feeding problems can build on each other. Another important aspect is how it may link with other diseases. In neonatal Marfan syndrome, serious valve problems in the heart can lead to heart failure, and that can make shortness of breath, poor feeding, and low weight gain harder to manage. Lung infections or other breathing illnesses may also hit harder, especially when the chest wall is shaped differently or the lungs are already under strain. Some babies and children with neonatal Marfan syndrome also have reflux or trouble gaining weight, which can add to fatigue and make recovery from illness slower. Because the early symptoms of neonatal Marfan syndrome can overlap with other heart or lung conditions, care is usually safest when cardiology, genetics, and pediatric teams follow the child together.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Neonatal marfan syndrome?
The main conditions that can look like neonatal Marfan syndrome are other genetic disorders that affect the body’s support tissues, especially Loeys-Dietz syndrome, Beals syndrome, and some forms of Ehlers-Danlos syndrome. These can also cause very long fingers, loose or stiff joints, a curved spine, an unusual chest shape, and serious heart or blood vessel problems early in life. Doctors may also compare it with more typical Marfan syndrome and, less often, homocystinuria, because some children with these conditions can have a similar body shape or eye problems.
History
Doctors first began to recognize that some newborns had a much more severe pattern of features than is usually seen in Marfan syndrome. These babies often had very long fingers and limbs, loose joints, feeding trouble, breathing problems, and serious heart valve disease in the first days or weeks of life. Over time, this distinct early form came to be known as neonatal Marfan syndrome, although many living with the condition today are described more broadly as having severe early-onset Marfan syndrome.
Initially understood only through symptoms, later it became clear that these infants were not simply showing Marfan syndrome at a younger age, but a particularly serious form that starts very early and can affect several body systems at once. In older medical reports, doctors mainly described what they could see at the bedside: a baby who struggled to gain weight, tired quickly with feeding, or developed signs of heart failure very early in life. As imaging and newborn care improved, the picture became clearer, especially the major role of heart and blood vessel problems.
In recent decades, awareness has grown as researchers linked neonatal Marfan syndrome to changes in connective tissue, the material that helps support the body’s heart valves, blood vessels, bones, eyes, and lungs. Researchers later identified a genetic cause, which helped confirm that this condition belongs within the Marfan spectrum, even though it often looks more severe in infancy than the classic form. That shift mattered because it improved diagnosis, helped families get more accurate counseling, and guided earlier heart monitoring and supportive care.
The history of neonatal Marfan syndrome also reflects how newborn medicine has changed. In the past, some affected infants may not have been recognized right away, especially if the most urgent concern was breathing or heart failure rather than body shape or joint looseness. Today, doctors are better able to connect those clues, so early symptoms of neonatal Marfan syndrome are more likely to be identified sooner, even though the condition remains rare.